Antimicrobial Sequencing

Antimicrobial Sequencing is a clinical decision-making framework that prescribes the systematic transition from intravenous to oral antimicrobial therapy based on patient-specific pharmacokinetic, pharmacodynamic, and clinical response criteria.

46

Publications

1.6K

Citations

412

Authors

143

Institutions

Publications per year

2017–2026

34

Variants

Intravenous-to-oral Switch TherapyIv-to-oral Switch Therapy

Publications

46

1–5 of 46

Authors

412

  1. MH
    Michael H. Silverman

    Can-Fite BioPharma (Israel), Israel

    2 publications · 36 citations

    2

    h-index

  2. KB
    Khurshida Begum

    University of Houston, United States

    2 publications · 36 citations

    2

    h-index

  3. AJ
    Anne J Gonzales-Luna

    University of Houston, United States

    2 publications · 36 citations

    2

    h-index

  4. MH
    Marta Hernández-García

    Instituto Ramón y Cajal de Investigación Sanitaria, Spain

    2 publications · 29 citations

    2

    h-index

  5. YB
    Yehudit Bergman

    Johns Hopkins University, United States

    2 publications · 78 citations

    2

    h-index

1–5 of 412

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 7 publications · 206 citations

    7

    h-index

  2. Open Forum Infectious Diseases

    OFID · 3 publications · 156 citations

    3

    h-index

  3. Microorganisms

    2 publications · 26 citations

    2

    h-index

  4. PLoS ONE

    2 publications · 45 citations

    2

    h-index

  5. BMC Infectious Diseases

    2 publications · 26 citations

    2

    h-index

1–5